SK284297B6 - Farmaceutický prostriedok obsahujúci ľudský albumín - Google Patents

Farmaceutický prostriedok obsahujúci ľudský albumín Download PDF

Info

Publication number
SK284297B6
SK284297B6 SK35-97A SK3597A SK284297B6 SK 284297 B6 SK284297 B6 SK 284297B6 SK 3597 A SK3597 A SK 3597A SK 284297 B6 SK284297 B6 SK 284297B6
Authority
SK
Slovakia
Prior art keywords
aluminum
albumin
citrate
concentration
glass
Prior art date
Application number
SK35-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK3597A3 (en
Inventor
Debart Pere Ristol
Torrecillas David Camarero
Original Assignee
Probitas Pharma, S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8293596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284297(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Probitas Pharma, S. A. filed Critical Probitas Pharma, S. A.
Publication of SK3597A3 publication Critical patent/SK3597A3/sk
Publication of SK284297B6 publication Critical patent/SK284297B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SK35-97A 1996-01-30 1997-01-10 Farmaceutický prostriedok obsahujúci ľudský albumín SK284297B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09600200A ES2103236B1 (es) 1996-01-30 1996-01-30 Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.

Publications (2)

Publication Number Publication Date
SK3597A3 SK3597A3 (en) 1997-08-06
SK284297B6 true SK284297B6 (sk) 2005-01-03

Family

ID=8293596

Family Applications (1)

Application Number Title Priority Date Filing Date
SK35-97A SK284297B6 (sk) 1996-01-30 1997-01-10 Farmaceutický prostriedok obsahujúci ľudský albumín

Country Status (13)

Country Link
US (1) US5846930A (ja)
EP (2) EP0787498B1 (ja)
JP (1) JP3054371B2 (ja)
AR (1) AR005374A1 (ja)
AT (1) ATE269717T1 (ja)
CZ (1) CZ289782B6 (ja)
DE (2) DE69632771T2 (ja)
DK (1) DK0787498T3 (ja)
ES (3) ES2103236B1 (ja)
HU (1) HUP9603601A3 (ja)
PT (1) PT787498E (ja)
SK (1) SK284297B6 (ja)
UY (1) UY24448A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
US6197936B1 (en) 1998-10-21 2001-03-06 Nissho Corporation Method for producing a plastic vessel containing an albumin preparation
US6693173B2 (en) * 2000-12-26 2004-02-17 Alpha Therapeutic Corporation Method to remove citrate and aluminum from proteins
GB0117879D0 (en) * 2001-07-21 2001-09-12 Common Services Agency Storage of liquid compositions
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
US6718735B2 (en) * 2002-03-19 2004-04-13 Baxter International Inc. Albumin in a flexible polymeric container
ES2221817B1 (es) 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
SE500110C2 (sv) * 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
ES2224094T3 (es) * 1990-04-19 2005-03-01 Bayer Corporation Procedimiento para preparar seroalbumina normal (humana) esencialmente monomerica.
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels

Also Published As

Publication number Publication date
EP0787498A2 (en) 1997-08-06
HU9603601D0 (en) 1997-02-28
HUP9603601A2 (en) 1997-08-28
EP1413312A3 (en) 2004-09-01
EP1413312A2 (en) 2004-04-28
JPH09221431A (ja) 1997-08-26
ATE269717T1 (de) 2004-07-15
US5846930A (en) 1998-12-08
AR005374A1 (es) 1999-04-28
EP0787498B1 (en) 2004-06-23
DE69632771T2 (de) 2005-07-07
DE69632771D1 (de) 2004-07-29
DE787498T1 (de) 1999-05-20
UY24448A1 (es) 1997-02-18
PT787498E (pt) 2004-10-29
ES2103236A1 (es) 1997-09-01
HUP9603601A3 (en) 1998-01-28
CZ697A3 (en) 1997-08-13
ES2103236B1 (es) 1998-04-16
ES2220256T1 (es) 2004-12-16
ES2220967T3 (es) 2004-12-16
DK0787498T3 (da) 2004-10-11
JP3054371B2 (ja) 2000-06-19
EP0787498A3 (en) 1998-10-21
CZ289782B6 (cs) 2002-04-17
SK3597A3 (en) 1997-08-06
MX9700617A (es) 1997-07-31

Similar Documents

Publication Publication Date Title
US5118794A (en) Process for stabilizing human albumin solutions and the solution obtained
EP1084147B1 (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
US6281336B1 (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
EP0196761B1 (en) Method of virus-inactivating heat treatment of gamma-globulin
JPS6241211B2 (ja)
SK284297B6 (sk) Farmaceutický prostriedok obsahujúci ľudský albumín
JPH0639388B2 (ja) 免疫グロブリン−g−含有フラクシヨン
KR20030084908A (ko) 단백질로부터 시트레이트 및 알루미늄을 제거하는 방법
SK32899A3 (en) Process for producing a plasma protein-containing medicament
SK8293A3 (en) Composition for stabilizing bloodplasma during pasteurization and pasteurized plasma solution for therapeutic use
JPH0530811B2 (ja)
RU2105550C1 (ru) Способ получения инъекционного раствора натрий-2-меркаптоэтансульфоната (месны)
KR100188318B1 (ko) 안정화된 주사제 및 주사제의 안정화법
MXPA97000617A (en) Human therapeutic albumin with low capacity for the fixation of alumi
US5834520A (en) Container for injectable mesna solutions
RU1803101C (ru) Способ получени глазных капель пилокарпина гидрохлорида
Solutions et al. Aluminium in Human
AU2004228847A1 (en) Process for producing albumin preparation
RU1825628C (ru) Способ получени глазных капель
Grangeorge et al. Process for stabilizing human albumin solutions and the solution obtained
JPH01268698A (ja) 安定な硫酸イセパマイシン注射用製剤

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20170110